<DOC>
	<DOCNO>NCT03003000</DOCNO>
	<brief_summary>To assess efficacy safety 400 mg ibuprofen/100 mg caffeine tablet comparison 400 mg ibuprofen tablet treatment acute lower back neck pain . To assess safety tolerability 400 mg ibuprofen/100 mg caffeine tablet comparison 400 mg ibuprofen tablet placebo tablet .</brief_summary>
	<brief_title>Ibuprofen/Caffeine Lower Back Neck Pain Study</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Neck Pain</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Inclusion criterion : Signed date write informed consent Visit 1 accordance Good Clinical Practice ( GCP ) local legislation . Male female patient &gt; =18 year current diagnosis acute back pain neck pain least 24 hour , less 21 day . Acute back pain acute neck pain result Pain Movement ( POM ) &gt; =5 010 Numerical Rating Scale ( NRS ) least one POM procedure 5 standardised procedure . Sensitivity algometric pressure painful trigger point &lt; = 25 N/cmÂ² . Women childbearing potential must ready able use highly effective method birth control . Reliable , cooperative , adequate intelligence record request information analgesic questionnaire . Examined attend physician medically clear participate study In good general health , body mass index ( BMI ) &lt; 30 , contraindication study medication Exclusion criterion : History 3 episode back neck pain last 6 month exclude current episode . Patients pain rest &gt; = 9 Patient chronic back neck pain define pain 3 week longer . Back neck pain attributable identifiable cause ( eg . disc prolapse , spondylolisthesis , osteomalacia , inflammatory arthritis , metabolic , neurological disease tumour ) Any strain back neck muscle document clinical evaluation anamnesis occur 21 day 3 month prior screen visit . Surgery due back neck pain rehabilitation due back neck pain last 12 month . Prior use within last 3 day Visit 1 concomitant use anti inflammatory drug , heparinoids , muscle relaxant analgesic ( include limit shortacting glucocorticoid , nonsteroidal antiinflammatory drug [ NSAIDs ] , herbal preparation ) indication indication . Spinal injection discontinue due time ( investigator 's judgment ) patient enrollment allow complete washout active ingredient base investigator 's judgment . Known severe hepatocellular insufficiency , severe renal insufficiency Gilbert 's syndrome ( Morbus Meulengracht ) Patients take Central Nervous System ( CNS ) psychotropic drug , nutritional supplement know psychotropic effect St. John 's Wort , Chapparal , Comfrey , Germander , Gin Bu Huan , Kava , Pennyroyal Skullcap , Valerian within two month take first dose study medication . Patients stable dos medication least two month allow study , long maintain dose throughout study , condition judge stable Principal Investigator Any medical condition would interfere efficacy safety assessment base investigator 's judgment ongoing clinical condition would jeopardize patient 's site personnel 's safety study compliance base investigator judgment Further exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>